Lobbying client

LYNDRA THERAPEUTICS

Ultra-long acting therapeutic medicine

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
31
Filed by
3
Reported in-house
—
Reported by firms
$1,265,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2019 to 2023

Filings

31 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2023
BGR GOVERNMENT AFFAIRS — reported
4th Quarter - Report (No Activity)
4th Quarter 2022
BGR GOVERNMENT AFFAIRS — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2022
BGR GOVERNMENT AFFAIRS — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2022
BGR GOVERNMENT AFFAIRS — reported
1st Quarter - Report
1st Quarter 2022
BGR GOVERNMENT AFFAIRS $40,000 reported
1st Quarter - Termination
1st Quarter 2022
ERVIN GRAVES STRATEGY GROUP, LLC $40,000 reported
4th Quarter - Report
4th Quarter 2021
BGR GOVERNMENT AFFAIRS $60,000 reported
4th Quarter - Report
4th Quarter 2021
ERVIN GRAVES STRATEGY GROUP, LLC $60,000 reported
3rd Quarter - Report
3rd Quarter 2021
BGR GOVERNMENT AFFAIRS $60,000 reported
3rd Quarter - Report
3rd Quarter 2021
ERVIN GRAVES STRATEGY GROUP, LLC $60,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ERVIN GRAVES STRATEGY GROUP, LLC 13 $675,000
BGR GOVERNMENT AFFAIRS 12 $450,000
ACG ADVOCACY 2 $140,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 23
Defense DEF 8
Pharmacy PHA 3

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.